Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
03/2010
03/11/2010WO2010026974A1 Process for production of sultone derivative
03/11/2010WO2010026873A1 Novel compound ceramidastin, process for production thereof, and use thereof
03/11/2010US20100062942 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/11/2010US20100062542 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins
03/11/2010US20100061948 Composition for skin whitening comprising artemisinine
03/10/2010EP1651628B1 Antibiotic compound
03/10/2010EP1556385B1 Heterocyclocarboxamide derivatives
03/10/2010EP1445257B1 2h-1-benzopyran compounds for use in a photochromic material
03/10/2010EP1023315B1 Methods and compositions for destruction of selected proteins
03/10/2010CN101668761A Novel functional compounds with an isosorbide or isosorbide isomer core, production process and uses of these compounds
03/10/2010CN101665497A Method for refining isosorbide by distillation and melt crystallization coupling technology
03/09/2010US7674923 atorvastatin calcium epoxide dihydroxy (AED) is described; AED can be used as a standard or marker in determining the amount of AED in a sample
03/04/2010WO2010024930A2 Cortistatin analogues and syntheses therof
03/04/2010WO2010023594A1 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
03/04/2010WO2010023322A1 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
03/04/2010WO2009155020A3 Production of 5-membered and 6-membered cyclic esters of polyols
03/04/2010US20100056807 Prostaglandin synthesis and intermediates for use therein
03/04/2010US20100056618 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
03/04/2010US20100056605 Oxidative degradation products of atorvastatin calcium
03/04/2010US20100056596 Resistance-repellent retroviral protease inhibitors
03/04/2010CA2734814A1 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
03/04/2010CA2733795A1 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
03/03/2010EP1753858B1 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
03/03/2010EP1664056B1 Fused pentacyclic polyethers
03/02/2010US7671219 Reacting a fullerene oxide and a carbonyl compound in the presence of a Lewis acid catalyst forming Fullerene 1,3-dioxolane; solar cells
03/02/2010US7671088 Water-soluble etoposide analogs and methods of use thereof
02/2010
02/28/2010CA2676759A1 Prostaglandin synthesis and intermediates for use therein
02/28/2010CA2639240A1 Prostaglandin synthesis and intermediates for use therein
02/25/2010WO2010020663A1 New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents
02/25/2010WO2009132032A3 Sonic hedgehog modulators
02/25/2010US20100048923 ATR Inhibitor
02/25/2010US20100048882 N-(7-((3aR,4R,7R,7aR)-7-methoxy-6,6-dimethyl-2-oxo-tetrahydro-3aH- [1,3]dioxolo[4,5-c]pyran-4-yloxy)-2-oxo-2H-chromen-3-yl)acetamide; heat shock protein 90 inhibitors; gene expression inhibition; anticarcinogenic agents; neuroprotective agents
02/25/2010CA2733688A1 New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents
02/24/2010EP2155755A1 Compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds
02/24/2010EP2155754A1 Method for the production of dianhydrohexitol diesters
02/24/2010EP2155178A1 Spiro compounds for treatment of inflammatory disorders
02/24/2010CN101654410A Processes for preparing bicyclo (3.1.0) hexane derivatives, and intermediates thereto
02/24/2010CN100591676C 2- and 2,5-substituted phenylketo-enols
02/23/2010US7667052 Bioactive substance
02/18/2010US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth
02/17/2010EP2152717A1 Processes for making epothilone compounds and analogs
02/17/2010EP2152265A1 New method for preparing isofagomine and its derivatives
02/17/2010CN101648959A Coumaronochromones compound and preparation and application thereof
02/17/2010CN101648958A Preparation method of dianhydride monomer containing chiral dianhydro-hexitol
02/17/2010CN101648957A Preparation method of sesamin phenol
02/17/2010CN100590124C Tricyclic androgen receptor modulator compounds and method
02/16/2010US7662976 Triptolide derivatives for modulation of apoptosis and immunosuppression
02/16/2010US7662851 Use of specific cyklolignans
02/11/2010WO2010015617A1 Process for producing carnosol from carnosic acid using hydrogen peroxide or peracids
02/11/2010WO2009128087A3 A method for synthesis of dibenzylidene sorbitol in high yields
02/11/2010US20100036138 Catalyst and method for producing carboxylic acid and/or carboxylic anhydride in the presence of the catalyst
02/11/2010CA2735393A1 Novel compositions containing isolated tetrameric type a proanthocyanadin and methods of use and manufacture
02/09/2010US7659404 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
02/09/2010US7659308 Concentricolide and its derivatives, process for preparing them, pharmaceutical composition comprising the same and its use
02/04/2010WO2010012761A1 Dimeric derivatives of artemisinin and application in anti-cancer therapy
02/04/2010US20100029756 Novel compositions containing isolated tetrameric type a proanthocyanadin and methods of use and manufacture
02/04/2010US20100029632 improved pharmacokinetics
02/04/2010US20100029484 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
02/04/2010CA2730489A1 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
02/03/2010EP2149577A1 New stereospecific method for the preparation of dioxa-bicyclooctane compounds
02/03/2010EP2149576A1 Isosorbide Nitrates having vasodilating activity
02/03/2010CN100586950C Method for removing methylene of gingili wood phenols
01/2010
01/28/2010WO2010010933A1 Heterocyclidene-n-(3,4-dihydro-2(1h)-quinazolin-5-yl) acetamide derivative
01/28/2010WO2010010101A1 Isosorbide nitrates having vasodilating activity
01/28/2010WO2009147237A9 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics
01/28/2010WO2009145357A8 Benzo [1, 4] diazepines substituted at the 1-position by a ring, for use as antidepressants
01/28/2010WO2009111428A4 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof
01/28/2010WO2009019005A8 Tricyclic bridged cyclopentanedione derivatives as herbicides
01/28/2010US20100022638 Isosorbide nitrates
01/28/2010CA2734991A1 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
01/28/2010CA2731574A1 Isosorbide nitrates having vasodilating activity
01/27/2010EP2147921A1 Process for production of coumarin dimer compound
01/27/2010EP2146998A1 Sorbitol conversion process
01/27/2010CN101633661A Process for preparing sodium cantharidinate
01/27/2010CN101633660A Novel abietane-type diterpene compound as well as preparation method and application thereof
01/27/2010CN101633659A Method for concentrating and purifying sesamin
01/26/2010CA2300407C 4-cyano-4-deformylsordarin derivatives
01/21/2010WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
01/21/2010US20100016154 Imaging system
01/21/2010US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
01/20/2010CN100582111C Process for the production of the spiroglycol
01/20/2010CN100582110C Cyclohexanone analog saturated triring(bridge)compound and its preparation method and uses
01/20/2010CN100582097C Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors
01/19/2010US7649099 two step processes of producing isosorbide from sorbitol; first step in presence of a solid acid catalyst; second step in presence of a second catalyst selected from sulfuric acid, phosphoric acid, hydrochloric acid and p-toluenesulfonic acid; cost efficiency, environmentally friendly; therapeutic uses
01/19/2010US7649014 Inhibit uncoupling protein-2 (UCP2); treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia
01/19/2010US7649006 Synthesis of epothilones, intermediates thereto and analogues thereof
01/19/2010CA2472115C Colorant compounds
01/14/2010US20100010240 Synthesis of polycyclic procyanidins
01/14/2010US20100010063 Heterocyclocarboxamide derivatives
01/14/2010US20100009935 Resistance-repellent retroviral protease inhibitors
01/13/2010EP2142521A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
01/13/2010CN100579981C 3,9-dioxaasterane compounds and preparation method and application thereof
01/12/2010US7645891 E.g., 4-(2-methyl-3-oxo-hept-6-en-2-yl)-2,2-dimethyl-[1,3]-dioxane chemical intermediate; chemical/metabolic stabilization of microtubuli; antitumor, -carcinogenic agents; malignant melanoma, acute lymphocytic/myelocytic leukemia; angiogenesis inhibitors; antiinflammatory/-arthritic agents; psoriasis
01/12/2010US7645863 Adding a second organic solvent to a concentrated moxidectin solution to obtain a weight ratio of 2:I to 6:I with respect to the first solvent; cooling and recovering crystals of 94-96% purity being 2-5% purer than the amorphous form; veterinary medicine; antithelmintics; parasiticides
01/12/2010US7645768 Production of polyketides and other natural products
01/12/2010CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
01/12/2010CA2346010C Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance
01/07/2010US20100004441 N-(5-Membered Aromatic Ring)-Amido Anti-Viral Compounds
01/07/2010US20100004234 Specific kinase inhibitors
01/06/2010EP2139900A2 Novel functional compounds with an isosorbide or isosorbide isomer core, production process and uses of these compounds
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 174